ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics.
Kakosaiou K, Panitsas F, Daraki A, Pagoni M, Apostolou P, Ioannidou A, Vlachadami I, Marinakis T, Giatra C, Vasilatou D, Sambani C, Pappa V, Manola KN.
Kakosaiou K, et al. Among authors: daraki a.
Leuk Lymphoma. 2018 Oct;59(10):2439-2446. doi: 10.1080/10428194.2018.1433298. Epub 2018 Feb 7.
Leuk Lymphoma. 2018.
PMID: 29411666